China Cord Blood Corp Stock Analysis, Valuation (NYSE:CO)

Add to My Stocks
$10.52 $0.2 (1.87%) CO stock closing price Feb 16, 2018 (Closing)
Watch Robo Advisor Video of CO Stock Analysis
China Cord Blood Corp
Updated on : Feb 16, 2018
previous close
CO 10.5 (0%)
S&P 500 2732.2 (0%)
Closing Price On: Feb 16, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Outpatient-Home care
Sector :
5 Quarter Revenue
Revenue Growth
Compared to the industry
Operating Profit
Operating Margin:
Sector Average:
5 Quarter Net Profit
Net Margins
LTM Margin
Compared to the industry
Recent Growth
Operating Margins
Net Margins
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
Industry PS :
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Equity:
Double Tap To Exit Full Screen

CO Stock Analysis

70 5 2

Investors can watch the Amigobulls China Cord Blood Corp stock analysis video here. Our CO analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

China Cord Blood Corp Stock Rating 3.9/5

We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for CO stock analysis. We also use relative valuation metrics like PE ratio and price to sales ratio for China Cord Blood Corp valuation analysis. China Cord Blood Corp stock rating encapsulates our opinion about the company based on the fundamentals.

Should you buy CO stock?

  • China Cord Blood Corp's revenue growth came in at 27.7% in 2018 Q2.
  • The TTM operating margin was good at 36.4% for China Cord Blood Corp.
  • LTM Net margins were good at 26.8% for China Cord Blood Corp.
  • The LTM ROE of 10.2% for China Cord Blood Corp is attractive.

Should you sell CO stock?

Comments on this video and China Cord Blood Corp stock

Investors can make use of the Amigobulls China Cord Blood Corp stock analysis to ascertain how CO stock fares in fundamental analysis investment criteria. Company's fundamentals remain one of the key driver of CO stock and helps investors in making good buy and sell decision.

China Cord Blood Corp revenue growth is an indicator of the demand for a company's products while profit margin is indicative of company's pricing power and pricing strategy. Technical analysis comes in handy to check whether the market sentiment is in line with the fundamental picture of the company.